Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Microcirculation. 2013 May;20(4):337–347. doi: 10.1111/micc.12023

Regulation of Cerebral Artery Smooth Muscle Membrane Potential by Ca2+-activated Cation Channels

Albert L Gonzales 1, Scott Earley 1
PMCID: PMC3573261  NIHMSID: NIHMS418604  PMID: 23116477

Abstract

Arterial tone is dependent on the depolarizing and hyperpolarizing currents regulating membrane potential and governing the influx of Ca2+ needed for smooth muscle contraction. Several ion channels have been proposed to contribute to membrane depolarization, but the underlying molecular mechanisms are not fully understood. In this review, we will discuss the historical and physiological significance of the Ca2+-activated cation channel, TRPM4, in regulating membrane potential of cerebral artery smooth muscle cells. As a member of the recently described transient receptor potential super family of ion channels, TRPM4 possesses the biophysical properties and upstream cellular signaling and regulatory pathways that establish it as a major physiological player in smooth muscle membrane depolarization.

Keywords: Cerebral Artery Smooth Muscle Cells, TRPM4, Membrane Potential

INTRODUCTION

The degree of arterial tone controlling blood flow within the microcirculation is dependent on the contractile state of smooth muscle cells encircling the vessel wall. Movement of ions across the plasma membrane determines resting membrane potential and myocyte contraction. The ions channels responsible for these responses are still being characterized. Depolarization of the plasma membrane triggers smooth muscle contraction by increasing Ca2+ influx through dihydropyridine-sensitive voltage-dependent (L-type) Ca2+ channels. The subsequent rise in intracellular [Ca2+] initiates calmodulin-dependent cross-bridge cycling, leading to myocyte shortening and arterial constriction. Due to the steep voltage sensitivity of L-type Ca2+ channels (45), small variations in membrane potential can elicit significant changes in smooth muscle intracellular Ca2+ and vessel diameter (7.5 nM mV−1 and 7.5 µm mV−1 respectively, for cerebral arteries) (45). Therefore, ion channels influencing resting membrane potential and governing the opening of L-type Ca2+ channels play an essential role in regulating the contractile state of vascular smooth muscle cells. Efflux of K+ has been established as the major mechanism leading to membrane hyperpolarization and myocyte relaxation (42, 46, 77, 90), but less is known of the ion channels physiologically responsible for membrane depolarization in vascular smooth muscle cells. In the present review, we will summarize the contribution of Ca2+-activated cation channels in establishing the resting membrane potential of cerebral artery myocytes and discuss the upstream mechanisms of channel regulation that are essential for smooth muscle cell contraction.

SMOOTH MUSCLE MEMBRANE POTENTIAL

Under normal physiological ionic gradients, the K+ equilibrium potential is approximately −80 mV, yet resting membrane potential is consistently reported in pressurized cerebral arteries to be more depolarized at around −45 mV (66). Therefore, K+ channel activity cannot completely determine membrane excitability. Channels permeable to cations (Ca2+ and Na+ influx) or anions (Cl efflux) are present in smooth muscle cells, but the ions triggering membrane depolarization in smooth muscle cells are still unclear. The predominant divalent cation current in smooth muscle cells are from voltage-dependent L-type Ca2+ channels, but these channels do not contribute to membrane excitability. Even though the inhibition of L-type Ca2+ channels and blocking Ca2+ influx by dihydropyridine compounds causes myocyte relaxation, it does not alter the resting membrane potential (46). Dihydropyridine-insensitive (T-type) Ca2+ channels have been reported in some, but not all, types of arterial smooth muscle cells (1, 4, 6, 67, 86, 91); however, due to their kinetic properties, including rapid inactivation and low active voltage range (−65 mV to −45 mV) (4), these channels are thought to have a more transient or specialized role. Thus, Ca2+ ions entering through L-type Ca2+ channels do not have a major role in regulation of membrane excitability preceding contraction.

Cl currents can be recorded from vascular smooth muscle cells (2, 10, 49, 74), but, because the molecular identities of these channels was only recently discovered and due to the lack of specific pharmacology the significance of these currents has been difficult to determine. Some Cl channel blockers, like DIDS (4,4'-diisothiocyanatostilbene-2,2'disulphonic acid), SITS 4,acetamino-4'isothiocyanatostilbene-2,2'-disulphonic acid), and IAA-94 are effective in inhibiting pressure-induced vasoconstriction (2), but others, including 9-AC (9-anthracene chloride) and niflumic acid, have no effect (65). It was later shown that many of the Cl channel blockers reported to reduce myogenic response also inhibited nonselective cation channels (103) and L-type Ca2+ channels (20). The strongest evidence for the involvement of Cl channels in smooth muscle cell regulation comes from recent reports examining the role of transmembrane protein 16A (TMEM16A), a Ca2+ activated Cl channel (10, 14). Hyposmotic solution-induced cell swelling activated Cl currents in arterial smooth muscle cells and were diminished following inhibition of TMEM16A channels through siRNA-mediated downregulation and channel specific blocking antibodies (10). Ca2+ activated Cl currents contribute to membrane depolarization and pressure-dependent vasoconstriction of cerebral arteries (10). Additionally, the small molecular blocker of TMEM16A, T16Ainh-A01, reduced Ca2+-activated Cl currents in isolated myocytes and relaxed pre-constricted mouse thoracic arteries (14). These experiments clearly show that Cl conductance can contribute to membrane excitability, but additional experiments are needed to further and more acutely elucidate the physiological contributions of these channels in cerebral arteries.

The Cl equilibrium potential (−30 mV) is slightly depolarized compared to resting membrane potential (−40 mV) of arterial myocytes, and due to the relatively small driving force the Cl conductance may yield only a small depolarization. In contrast, the ionic gradient for Na+ is relatively large (ENa = +60 mV), and replacement of Na+ with the non-permeable cation NMethyl-D-glucamine (NMDG) causes myocyte hyperpolarization in rabbit posterior cerebral arteries (38). In addition, swelling- or pressure-induced depolarization of rat cerebral artery myocytes are reported to arise from activation of cation channels (15, 103). These findings strongly suggest that cation influx, in particular, Na+ ions, is a major contributor to membrane depolarization, but molecular identity of the ion channels responsible was not determined. The presence of conventional voltage-gated Na+ channels in arterial smooth muscle cells has been a point of controversy. Tetrodotoxin-sensitive Na+ currents are present in various types of cultured arterial myocytes (11, 56, 76, 78) and portal vein smooth muscle cells (87), but were not detected from cerebral arteries (36) and freshly isolated smooth muscle cells (56, 78). The isolation protocol used to liberate smooth muscle cells from arteries may influence detection of Na+ channels (8). In one study, when the serine protease elastase was used to enzymattically dissociated cells from mesenteric arteries, Na+ channel activity was detected, but when the cysteine protease papain was used Na+ currents were absent (8). Additional experiments examining the effects of cell culturing and enzymes digestion on voltagegated Na+ channels are required to determine the presence or contributions of this family of ion channels in the resting membrane potential of arterial smooth muscle cells.

Ca2+-activated non-selective cation channels (NSCCa) have been observed in numerous cell types (97), and until recent years the molecular identity and physiological significance of these channels were unknown. Since their first discovery by Hamill et al (1981), NSCCa currents have been recorded from numerous cell types, including; fibroblasts, mast cells, sensory neurons, cochlear outer hair cells, renal tubules, cardiac myocytes, and capillary endothelium (for review see (97)). The biophysical properties of NSCCa channels distinguish them from other channels (Figure 1). NSCCa channels have a unitary conductance ranging from 18–34 pS, are selective for monovalent cations with a low or undetectable Ca2+ permeability (PCa/PNa = 0–0.14), and are activated by intracellular Ca2+ (97). Channels within this group exhibit a diverse range of Ca2+ sensitivities (100 nM to 100 mM) (97). In pancreatic acini, NSCCa channels required 100 nM intracellular Ca2+ for activation, but following exposure to Ca2+ currents rapidly inactivate (53). Sturgess et al. (1986) showed that NSCCa channels are also inhibited by intracellular ATP (92). NSCCa channels until recently have rarely been associated with a clear physiological function in any of the aforementioned cell types (97). In excitable cells, NSCCa channels were proposed to be a major contributor to long lasting membrane depolarization (75), but due to lack of pharmacology and molecular tools at the time of this study the channel's molecular nature was not resolved.

Figure 1. Comparison of Nonselective Ca2+-activated cation channels (NSCCa), recombinant human TRPM4 channels expressed in HEK 293 cells, and native TRPM4 channels in vascular smooth muscle cells (VSMC).

Figure 1

ATP, adenosine triphosphate; PM, plasma membrane; SR, sarcoplasmic reticulum; 9-phen, 9-phenanthrol; PKC, Protein Kinase C; and PIP2, phosphatidylinositol 4, 5-bisphosphate.

TRPM4

The discovery of the mammalian Transient Receptor Potential (TRP) superfamily of cation channels in 1995 provided novel insight into the molecular identity of NSCCa channels and the ion channels responsible for smooth muscle membrane depolarization. The TRP superfamily consists of 28 gene products forming cation channels that respond to extracellular stimuli and mediate responses to chemical compounds and changes in temperature, osmolarity, light, and pressure (59). TRP channels are subdivided into six subfamilies: TRPA (ankyrin, 1), TRPC (canonical, 1–7), TRPM (melastatin, 1–8), TRPML (mucolipin, 1–3), TRPP (polycystin, 1–3), and TRPV (vanilloid, 1–6). Several Ca2+-permeable members of the TRPC, TRPV, TRPM, TRPP channels are involved in smooth muscle cell intracellular Ca2+ homeostasis and dynamics, including receptor-activated and mechanosensitive calcium entry (for review see (22, 23)). Non-selective cation-conducting TRP channels, including TRPC3 and TRPC6, can conduct Na+ as well as Ca2+ and have important roles in smooth muscle membrane excitability in cerebral arteries (81, 102). TRPC3 channels are involved in receptor-mediated membrane depolarization and constriction of arterial smooth muscle (81), whereas TRPC6 channels are intrinsically mechanosensitive (89) and contribute to pressure-dependent membrane depolarization of cerebral arteries (102). However, due to little, or no, ion selectivity of these channels, the downstream contribution of either Na+ or Ca2+ ions is still debated. Additional work is needed to determine whether Na+ influx via TRPC3 or TRPC6 initiates membrane depolarization, or if Ca2+ influx through these channels activate a downstream Ca2+ sensitive mechanism influencing membrane depolarization. One member of the TRPM subfamily of TRP channels, TRPM4, is present in cerebral arteries and due to its ion selectivity it has become a prime candidate for the regulation of membrane depolarization and smooth muscle contraction.

TRPM4 and its closest relative TRPM5 have biophysical properties that differ from other members of the TRP channel superfamily, and are reminiscent of NSCCa channels (Figure 1). TRPM4 and TRPM5 channels do not conduct Ca2+ but are highly selective for monovalent cations (50). As determined by ion substitution experiments in HEK 293 expression systems, TRPM4 is equally permeable for Na+ and K+, and to a lesser extent, Cs+ and Li+ (Na+ ≈ K+ > Cs+ > Li+) (69). Additionally, replacement of extracellular Na+ with the non-permeable cation NMDG+ has little effect on outward currents at depolarizing potentials, but completely abolished inward currents at hyperpolarizing potentials, suggesting that Na+ is the major ion conducted at physiological membrane potentials (69). The current-voltage (IV) relationship from single-channel recordings of inside-out patches in symmetrical cation solutions exhibits a non-rectifying conductance of ~25 pS (50). Conventional whole-cell macroscopic currents recorded from TRPM4-expressing HEK 293 cells exhibit a large outward and smaller inward rectification (50, 69). TRPM4 is not considered to be classically voltage-dependent. Although shifts in the resting membrane potential can increase or decrease the total open probability of the channel, changes in voltage do not gate it, with channel activation being primarily dependent on intracellular Ca2+ concentrations.

TRPM4 has an unusual relationship with Ca2+, as Ca2+ is required to stimulate the channel but also leads to channel inactivation. TRPM4 channel activity is dependent upon a rise in intracellular Ca2+ above global resting levels. Under whole-cell conditions, channels are more sensitive to Ca2+ (EC50 = 400 nM) (50) compared with recordings from the inside-out configuration (EC50 = 200 μM) (26, 69). This difference in Ca2+ sensitivity suggests the presence of a Ca2+-sensitive intracellular channel modulator under whole cell conditions that is lost when membrane patches are excised. In addition to requiring Ca2+ for activation, TRPM4 exhibits a rapid Ca2+-dependent inactivation, leading to loss of current within two minutes following exposure to high global Ca2+ (25, 26, 50, 68, 71). The channel's Ca2+ sensitivity may provide insight to regulatory mechanisms, where high Ca2+ is required for activation, but prolonged exposure or improper removal of Ca2+ leads to loss of channel activity.

Ca2+ sensitivity of TRPM4 is regulated by several intracellular pathways. The channel contains a putative phosphatidylinositol 4, 5-bisphosphate (PIP2) binding site, five calmodulin binding sites, several Protein Kinase C (PKC) phosphorylation sites, and six possible ATP-binding sites (68, 70, 71). PIP2 modulates channel activity by shifting the IV relationship resulting in an increase in TRPM4 current magnitude at negative holding potentials (68). Blocking of phospholipase C (PLC) activity (68) or including PIP2 in the recording pipette solution (68, 105) can prevent Ca2+-dependent inactivation. Maintaining channel activity by supplementing the cells with a phospholipid source or inhibiting phosphoinositide 3-kinase activity suggests the involvement of Ca2+-dependent PLC isoforms (82) in regulating channel activity. With five possible binding sites, two on the N-terminus and three on the C-terminus, the Ca2+ binding protein calmodulin can directly influences the Ca2+ sensitivity of TRPM4 (71). Overexpression of a truncated C-terminus mutant for TRPM4 or expression with dominant negative calmodulin mutants drastically decreases the amplitude of Ca2+-activated TRPM4 currents (71). TRPM4 also contains multiple possible interaction sites for PKC, suggesting phosphorylation-dependent modulation of the channel. The PKC activating compound phorbol 12-myristate 13- acetate (PMA) increased the incidence of occurrence and current density of TRPM4 channels by enhancing the Ca2+ sensitivity of the channel (71). Intracellular ATP inhibits TRPM4 currents with a half maximal inhibitory concentration (IC50) around 2–19 μM (70). TRPM4 is also modulated by adenine nucleotides with the highest sensitivity to ADP and least to adenosine (ADP > ATP > AMP >> adenosine) (72). The nucleotide triphosphates GTP, UTP, and CTP have no effect at concentrations lower than 1 mM (72). In addition to the inhibition of TRPM4 by free ATP, higher concentrations (in the millimolar range) can prevent Ca2+-dependent inactivation of the channel (71). Mutations of putative ATP binding sites on TRPM4 abolish this effect, indicating that prevention of Ca2+-dependent inactivation is associated with direct binding of ATP to the channel (71). In a similar manner, heat shifts the voltage-dependent activation curve for TRPM4 (Q10 = −5.6 ± 0.5 mV °C−1) (95), a phenomenon also observed in other thermosensitive TRP channels (17, 24). Modulation of the monovalent cation conductance through TRPM4 by voltage, adenine nucleotides, phospholipids, and heat and dependence on intracellular Ca2+ for activation are consistent with NSCCa channels previously described in many cell types, suggesting the identity of these channels as TRPM4.

The pharmacology for TRPM4 is limited. The most commonly used TRPM4 blockers include flufenamic acid, spermine, Gd3+, and sulfonylurea glibenclamide (16, 69, 72, 99) are poorly selective. Recently, a hydroxytricyclic derivative, 9-phenanthrol, has been shown to inhibit TRPM4 current with no effect on its closest relative TRPM5 (33). Additionally, at a concentration that nearly abolished TRPM4 channel activity (33), 9-phenanthrol did not alter TRPC3, TRPC6, voltage-gated K+ Channels (Kv), large-conductance Ca2+-activated K+ channels (BKCa), inwardly rectifying K+ channels (KIR), or L-type Ca2+ channel currents (32). These data suggest that 9-phenanthrol may be a specific inhibitor of TRPM4. Pharmacological activators for TRPM4 include decavanadate (70) and the pyrazole derivative BTP2 (N-[4–3, 5-bis(trifluromethyl)pyrazol-1-yl]-4-methyl-1,2,3-thiadiazole-5-carboxamide) (94), however, these agents also lack specificity. Decavanadate interferes with ATP-dependent inhibition of TRPM4 channel activity but can also interact with other ion channels, including IP3R and purinoreceptors (P2X) (57). BTP2 increases TRPM4 channel activity and reduces Ca2+-dependent inactivation, but can also inhibit TRPC3 and TRPC5 channels (37). 9-phenanthrol is currently the most useful pharmacological tool for unmasking the functional significance of TRPM4.

With the advancements of molecular techniques, previous observations of NSCCa currents now can be identified as TRPM4 channels. Similar to the broad distribution reported for NSCCa channels, TRPM4 channels have been detected at high levels in the heart, pancreas, placenta, and prostate (for review see (35)), and with lower levels of TRPM4 detected in kidney, skeletal muscle, liver, intestines, thymus, and spleen (35). The functional significance and expression of TRPM4 have been extensively characterized in four cell types. TRPM4 regulates cytokine secretion in lymphocytes and insulin secretion in pancreatic β-cells (for review see (88)). TRPM4 plays a role in controlling respiratory rhythmogenesis in neurons of the pre-Bötzinger complex (for review see (34)). Gain of function mutations within the TRPM4 gene in Purkinje fibers suggests it plays a role in isolated cardiac conduction disease in human heart (for review see (34)). Lastly, and as the focus of the current review, TRPM4 is essential for smooth muscle membrane depolarization and vasoconstriction in cerebral arteries.

TRPM4 IN CEREBRAL ARTERY SMOOTH MUSCLE CELLS

TRPM4 channels are present and functionally critical for the regulation of cerebral artery tone (26). Inside-out patch clamp recordings from freshly isolated cerebral artery smooth muscle cells in symmetrical cation solutions demonstrate a monovalent cation-selective and Ca2+-dependent (EC50 = 200 μM) current with unitary conductance suggestive for TRPM4 (~24 pS) (26). Single channel activity exhibited a linear voltage dependency, with inward currents at negative potentials, reversal at 0 mV, and outward currents at positive potentials (26). Ion substitution experiments revealed the channel to be selective for Na+ ions (26), and suppression of TRPM4 expression via antisense technology decreased channel activity, establishing the molecular identity of these currents as TRPM4 (26). Downregulation of TRPM4 impaired smooth muscle depolarization and myogenic constriction of isolated cerebral arteries (26). In addition, in vivo knockdown of TRPM4 expression impaired autoregulation of cerebral blood flow in living animals (80). Following suppression of the channel by infusion of antisense oligodeoxynucleotides targeting TRPM4 into rat cerebral spinal fluid, blood flow was recorded to be higher at resting and elevated mean arterial pressures (80). These were the first findings to demonstrate the functional significance of TRPM4 as a major contributor to cerebral blood flow regulation. The channel blocker 9-phenanthrol was employed to further and more acutely examine the role of TRPM4 in cerebral arteries. Blocking of TRPM4 currents with 9-phenanthrol reversibly hyperpolarizes smooth muscle cells leading to dilation of cerebral arteries (32). Consistent with these findings, 9-phenanthrol was used to pharmacologically identify TRPM4 as the major contributor to resting membrane potential in human and monkey colonic smooth muscle cells (21). These findings demonstrate the functional significance of TRPM4 channels in the regulation of smooth muscle cell membrane potential.

In contrast with the findings discussed above, recent studies using TRPM4 knockout (TRPM4−/−) mice reported no difference in myogenic tone in arteries from mouse hind limbs (54). One explanation is that the relationship between membrane potential and myogenic tone can vary between arteries of different vascular beds. In cerebral arteries, vascular tone as a function of membrane potential exhibits a near linear relationship (45), while in skeletal muscle arterioles this relationship is reported to be sigmoidal or non-linear (47). This difference between arteries of two vascular beds may suggest variations in the mechanism that regulate arterial tone. Alternatively, compensatory mechanisms may exist within knockout mouse systems. For example, TRPC6 deficient (TRPC6−/−) mice exhibited a higher mean arterial blood pressure compared to controls, but this was associated with an upregulation of TRPC3 channels (19). Changes in expression levels of other TRP channels in TRPM4−/− mice were not reported, so possible compensation by other channels cannot be ruled out. Further experiments are warranted to resolve these issues.

Elucidation of cellular pathways that regulate TRPM4 channels in cerebral artery smooth muscle cells have been hampered by the channel's intrinsic and rapid Ca2+-dependent inactivation (26, 31, 50). Micromolar concentrations of Ca2+ traditionally have been included in the recording pipette to activate TRPM4 channels following cellular dialysis under conventional whole-cell recording conditions. Within a few minutes following exposure to high Ca2+, TRPM4 activity rapidly inactivates (50, 69). Block of PLC activity or including PIP2 in the recording pipette solution can rescue the channel from inactivation (68, 105). These observations suggest that loss of channel activity could be an artifact of conventional whole cell recording conditions. High intracellular concentrations of Ca2+ maintained following dialysis may over-stimulate Ca2+-dependent PLC isoforms leading to depletion of local PIP2 stores. To test this possibility, an amphotericin B perforated patch-clamp configuration was employed in which whole cell currents were recorded with minimal disruption of subcellular Ca2+ signaling pathways (39). This patch-clamp method allowed novel sustained inward cation currents to be recorded from native cerebral artery smooth muscle cells for as long as seal viability could be maintained (> 30 min). These currents are referred to as “transient inward cation currents” (TICCs) (30). TICCs have an apparent single channel conductance of ~25 pS, reverse near 0 mV in symmetrical cation solutions, and channel activity is lost following substitution of extracellular Na+ with impermeant cation NMDG (30). TICC activity was inhibited by TRPM4-blockers flufenamic acid and 9-phenanthrol, and is attenuated by siRNA-mediated downregulation of TRPM4 expression in cerebral artery myocytes (30). These findings demonstrate that the molecular identity of the channel responsible for TICC activity is TRPM4 (Figure 1). Recording of sustained TRPM4 currents under the perforated patch-clamp technique provides a novel method for further characterization of channel activity under near-physiological conditions in smooth muscle cells.

The ability to record sustained channel activity from native cells without major disruption of intracellular Ca2+ dynamics has allowed TRPM4 channel regulation to be characterized. TRPM4 requires [Ca2+] above resting cystolic levels for activation. In freshly isolated cerebral artery smooth muscle cells, removal of extracellular Ca2+ did not acutely affect TRPM4 channel activity (30, 31). Blocking of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) rapidly inhibited TICC activity, suggesting that Ca2+ released from internal stores activated the channel (30, 31). Inhibition of inositol trisphosphate receptors (IP3R), but not ryanodine receptors, diminished TICC activity, suggesting that TRPM4 channels are activated by Ca2+ released from the sarcoplasmic reticulum (SR) via IP3R (30, 31). In agreement with these findings, the membrane permeable inositol trisphosphate (IP3) analog Bt-IP3 increased TICC activity (31). This effect was lost when cells were pretreated with the IP3R blocker xestospongin C (31), providing further evidence to the involvement of IP3R in the activation of TRPM4 channels. The coupling between TRPM4 and IP3R was also reported for the neonatal mouse preBötzinger complex, where the channels contribute to neuronal control of respiratory rhythms (13). These data suggest that a Ca2+ release event culminating from IP3R within in the SR membrane activates TRPM4 channels located in the plasma membrane.

Changes in cytosolic Ca2+ dynamics influence IP3R-dependent activation of TRPM4. Using immunocytochemistry and membrane specific staining, IP3Rs in the SR membrane and TRPM4 channels located on the plasma membrane were found to be proximal to each other (31). These findings were complemented by conventional whole cell patch clamp experiments where the Ca2+ buffers ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) or bis-ethane-N,N,N′,N′-tetraacetic acid (BAPTA) were included in the pipette solution and dialyzed into the cell under the whole cell configuration. BAPTA and EGTA have identical steady-state kinetics and Ca2+ binding affinities, but significantly differ in their binding rate constants (3). BAPTA can bind free Ca2+ at a rate that is two orders of magnitude faster than EGTA (3). IP3R-mediated activation of TRPM4 was observed when 10 mM EGTA but not 10 mM BAPTA (31) was included in the recording pipette. This difference in channel activity by equal concentrations of BAPTA or EGTA suggests that the IP3R-mediated activation of TRPM4 occurs within spatially restricted domains. Ca2+ microdomains, with a Ca2+ source-to-sensor distance of greater than 50 nm, are defined by Ca2+-dependent responses that are equally disrupted by identical concentrations of BAPTA and EGTA (62). In contrast, Ca2+ nanodomains, with a Ca2+ source-to-sensor distance less than 50 nm, are defined by Ca2+-dependent responses that are significantly interfered with by BAPTA, but not by equal concentrations of EGTA (62). Therefore, the difference in channel activity in the presence of equal concentrations of BAPTA vs. EGTA, suggests that TRPM4 channels and IP3Rs are located no more than 50 nm apart within Ca2+ nanodomains (Figure 2) Additionally, loss of TRPM4 channel activity following Ca2+ chelation with BAPTA provides electrophysiological evidence that the IP3R-mediated activation of TRPM4 channels occurs via a Ca2+ release event and that these signaling events occur within nanodomains where the SR and plasma membranes are in close proximity.

Figure 2. Simulation of TRPM4 by Ca2+ Nanodomain Created by Ca2+ released from the Sarcoplasmic Reticulum via IP3R.

Figure 2

In freshly isolated smooth muscles, TRPM4 activation requires Ca2+ released from the SR through proximal IP3R. The Ca2+ concentration profile comparing the buffering capacity of the slow and fast Ca2+ chelators EGTA and BAPTA on [Ca2+]i as a function of distance from a single IP3R Ca2+ release site. Simulation data using CalC software v. 6.0 (55) was re-plotted from Gonzales and Earley (31).

Ca2+ is an important second messenger for multiple overlapping intracellular signaling pathways. TRPM4 channels are activated by micromolar levels of cytosolic Ca2+, and recent work suggests that localized and transient release of Ca2+ from intracellular stores through IP3R activates TRPM4 channels. IP3Rs are also influenced by intracellular Ca2+, but at much lower concentrations and exhibit a biphasic sensitivity where Ca2+ activates and inactivates the channel within a nanomolar range (300 nM) (40, 41). Ca2+ can excite or inhibit IP3Rs directly at several distinct Ca2+ binding sites within the channel (for review see (63)) or indirectly by interfering with binding of IP3 to the channel (5). Additionally, binding of IP3 to IP3R increases the Ca2+ sensitivity of channel (52) and the interplay between intracellular Ca2+ and IP3 binding to IP3R contributes to the versatility and hierarchical recruitment of observed Ca2+ signaling events. In response to increased levels of cytosolic IP3, individual IP3Rs are activated giving rise to unitary events (Ca2+ blips) (9, 93), then clusters of IP3Rs open together (Ca2+ puff) (79, 93, 96), and ultimately these events propagate from one cluster to another (Ca2+ waves) (61). The particular IP3R-mediated Ca2+ release event physiologically important for activation of TRPM4 in cerebral artery myocytes is still not known, but recordings of sustained TRPM4 channel activity from smooth muscle cells suggest that PLC-dependent generation of IP3 and intracellular Ca2+ required for IP3R activation are continuously present. Separation of the IP3R-dependent Ca2+ release event from the Ca2+ signaling pathways initially regulating IP3R function can be achieved through the difference of Ca2+ sensitivity between TRPM4 and IP3R. Low levels of intracellular Ca2+ can modulate communication between IP3Rs without affecting TRPM4 channel activity and smooth muscle membrane depolarization. Additionally, signaling events initiated distal to SR/plasma membrane junctions can propagate between neighboring IP3Rs towards nanodomains where IP3R-dependent activation of TRPM4 channels occurs. These two tiers of Ca2+ sensitivity, with low nanomolar concentrations of Ca2+ stimulating IP3Rs and higher micromolar concentrations activating TRPM4 channels, provides a separation and prevention of crosstalk between Ca2+ signaling events. This arrangement allows for multiple localized Ca2+ events to occur concurrently without stimulating TRPM4-mediated membrane depolarization and myogenic constriction.

Generation of myogenic tone requires PLC activity (73), but the mechanism behind PLC-dependent membrane depolarization and myocyte contraction is still not clear. Recent findings showing that TRPM4-mediated membrane depolarization requires Ca2+ released from IP3Rs in the SR which may provide insight to PLC-dependent vasoconstriction. Production of the endogenous IP3R activator IP3 occurs through the hydrolysis of PIP2 by PLC, and, in arterial smooth muscle cells, the intracellular concentration of IP3 (64) and PLC activity (73) are positively correlated with changes in arterial intraluminal pressure. Additionally, pharmacological inhibition of PLC results in smooth muscle membrane hyperpolarization and disruption of sustained pressure-induced constriction of arteries (44, 73). Therefore, tonic PLC activity could generate intracelluar IP3 levels required for IP3R activation and TRPM4-mediated smooth muscle membrane depolarization and maintenance of cerebral vascular tone. Multiple isoforms belonging to three families (β, γ, and δ) of PLC have been detected in vascular smooth muscle cells (51). Extracellular agonists bind to G protein-coupled receptors located on the plasma membrane and may activate PLCβ isoforms leading to receptor-mediated vasoconstriction. Early reports observed a considerable suppression of pressure- and agonist induced tone following the inhibition of tyrosine kinase, an upstream activator of PLCγ isoforms (18, 73). The direct influence of PLCβ or PLCγ isoforms on TRPM4 channel activity has not been shown, but generation of IP3 and activation of sustained IP3R-mediated TRPM4 currents could provide the depolarizing stimulus for PLC-dependent contractions. In addition, PLC has several upstream and downstream effects, expanding the possible interactions and molecular pathways that may influence TRPM4-mediated smooth muscle membrane depolarization and vasoconstriction.

PKC plays an important role in regulating basal arterial tone in cerebral arteries (25, 43, 84). Stimulation of PKC activity increases the Ca2+-sensitive activation of TRPM4 currents (71), and in cerebral artery myocytes PMA elicits TRPM4-dependent membrane depolarization and arterial constriction (25). To further elucidate the mechanism of PKC-dependent increases in cation current, cell surface biotinylation and TIRF microscopy were used to examine the expression of TRPM4 protein in the plasma membrane (12). Following PKC stimulation, TRPM4 channels rapidly translocated (~5 minutes) to the plasma membrane in A7r5 cells, primary cerebral artery myocytes, and intact arteries (12). This effect was lost following selective inhibition of PKCδ, but not following blocking of PKCα and PKCβ (12). RNAi-mediated downregulation or pharmacological inhibition of PKCδ caused TRPM4 channels to translocate from the plasma membrane into the cytosol (29), suggesting that tonic PKCδ activity is required to maintain surface expression of TRPM4. Channel activity was inhibited following the administration of the PKCδ blocker rottlerin (29), and suppression of PKCδ expression hyperpolarized smooth muscle cells and impaired vessel constriction in response to both PMA and increases in intraluminal pressure in intact cerebral arteries (12). These findings provide a novel mechanism for the regulation of smooth muscle excitability through the dynamic trafficking of TRPM4 channels to and from the plasma membrane, and indicate that PKC-dependent increases in Ca2+ sensitivity of the channel may result from elevated levels of TRPM4 protein at the cell surface.

TRPM4 IN HYPERTENSION

Smooth muscle hyperexcitability leading to increased peripheral resistance within the microvasculature contributes to the development of essential hypertension (28). In vascular smooth muscle cells, the regulation and permeability of K+ and Ca2+ are altered during this disease, but involvement of TRPM4 channel activity has not been reported. In many hypertensive human and animal models, elevated vascular tone has been reported and is associated with a more depolarized resting membrane potential and disrupted Ca2+ handling (101). L-type Ca2+ current density in vascular smooth muscle cells from spontaneous hypertensive rats (SHR) is increased compared to their normotensive Wistar-Kyoto (WKY) controls (86, 101), leading to an increase in basal intracellular Ca2+ concentrations. In addition, BKCa channel activity is increased under hypertensive conditions (27, 85). The open probability of BKCa channels increases at more positive potentials, suggesting that increased channel activity during hypertension results from amplified depolarizing currents. TRPM4 is an intriguing potential contributor to this pathophysiological condition, as several of the molecular pathways that regulate its activity have also been shown to be altered under these conditions. For example, PLC activity and the generation of IP3 increase in response to intraluminal pressures (64), and basal intracellular IP3 concentrations are elevated in genetically hypertensive rats (7, 58, 83, 98, 100, 104). Although no difference in IP3R expression or IP3R-mediated Ca2+ release has been reported, an increase in intracellular IP3 level together with elevated cytosolic Ca2+levels could increase tonic IP3R-mediated TRPM4 channel activity and membrane depolarization. PKC activity has also been linked with pressure-dependent vasoconstriction and PMA-mediated activation of PKC enhances myogenic activity (60). Inhibition of PKC in cerebral arteries has a significantly greater effect on myogenic tone in cerebral arteries isolated from SHR rats compared to WKY controls (43), suggesting an increase in PKC activity during hypertension. Surface expression of TRPM4 channels is dynamically regulated by PKC (12) and the observed increase in PKC activity in SHR rats can lead to more channels localized in the plasma membrane. Interestingly, a missense mutation of TRPM4 impaired the endocytosis of channels leading to elevated channel density at the plasma membrane, contributing to the development of progressive familial heart block type 1 in humans (48). Mutations with similar effects on TRPM4 distibution in vascular smooth muscle cells could lead to higher tonic TRPM4 channel activity, increased membrane depolarization, and ultimately contribute to smooth muscle hyperexcitability, thereby contributing to hypertension. Additional studies investigating the involvement of TRPM4 in hypertension are needed to test this hypothesis.

CONCLUSION

The discovery of TRPM4 has unmasked the molecular identity of one type of NSCCa channel that was first described in 1981. TRPM4 processes biophysical properties and broad distribution reminiscent of NSCCa channels. In addition, TRPM4 channels are selective for monovalent cations, activated by, but impermeable to, Ca2+, and are regulated by components of the PLC and PKC pathways (Figure 3). Advancements in the ability to record TRPM4 channel activity in native smooth muscle cells has allowed for further insight to the signaling complexes that regulate the channel. It is apparent that TRPM4 is an essential ion channel for cerebral artery myocyte depolarization leading to contraction, but additional studies are needed to fully elucidate the possible complementary and integrative role it may play with other ion channels proposed to influence smooth muscle depolarization. More importantly, the pathophysiological role of TRPM4 in vascular dysfunction associated with hypertension, stroke, and other cardiovascular diseases warrants further investigation.

Figure 3. Regulation of TRPM4 Activity in Contractile Cerebral Artery Smooth Muscle Cells.

Figure 3

PM, plasma membrane; SR, sarcoplasmic reticulum; PKCδ, protein kinase C; PIP2, phosphatidylinositol 4, 5-bisphosphate; PLC, phospholipase C; IP3, inosital triphosphate; IP3R, inosital triphosphate receptor; VM, membrane potential; and VGCC, voltage gated calcium channels.

ACKNOWLEDGEMENTS

We thank Michelle N. Sullivan for critical comments on the manuscript.

Sources of Support: This work was supported by NIH grants RO1HL091905 (SE) and F31HL094145 (ALG); National American Heart Association Scientist Development Grants AHA0535226N (SE); and Monfort Excellence Award (SE).

REFERENCES

  • 1.Aaroson PI, Bolton TB, Lang RJ, MacKenzie I. Calcium currents in single isolated smooth muscle cells from the rabbit ear artery in normal-calcium and high-barium solutions. J Physiol. 1988;405:57–75. doi: 10.1113/jphysiol.1988.sp017321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aickin CC, Brading AF. The effect of loop diuretics on Cl- transport in smooth muscle of the guinea-pig vas deferens and taenia from the caecum. J Physiol. 1990;421:33–53. doi: 10.1113/jphysiol.1990.sp017932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Allbritton NL, Meyer T, Stryer L. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science. 1992;258:1812–1815. doi: 10.1126/science.1465619. [DOI] [PubMed] [Google Scholar]
  • 4.Bean BP, Sturek M, Puga A, Hermsmeyer K. Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ Res. 1986;59:229–235. doi: 10.1161/01.res.59.2.229. [DOI] [PubMed] [Google Scholar]
  • 5.Benevolensky D, Moraru II, Watras J. Micromolar calcium decreases affinity of inositol trisphosphate receptor in vascular smooth muscle. Biochem J. 1994;299(Pt 3):631–636. doi: 10.1042/bj2990631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Benham CD, Hess P, Tsien RW. Two types of calcium channels in single smooth muscle cells from rabbit ear artery studied with whole-cell and single-channel recordings. Circ Res. 1987;61:I10–16. [PubMed] [Google Scholar]
  • 7.Bernier S, Guillemette G. Increased inositol 1,4,5-trisphosphate binding capacity in vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens. 1993;6:217–225. [PubMed] [Google Scholar]
  • 8.Berra-Romani R, Blaustein MP, Matteson DR. TTX-sensitive voltage-gated Na+ channels are expressed in mesenteric artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005;289:H137–145. doi: 10.1152/ajpheart.01156.2004. [DOI] [PubMed] [Google Scholar]
  • 9.Bootman MD, Berridge MJ, Lipp P. Cooking with calcium: the recipes for composing global signals from elementary events. Cell. 1997;91:367–373. doi: 10.1016/s0092-8674(00)80420-1. [DOI] [PubMed] [Google Scholar]
  • 10.Bulley S, Neeb ZP, Burris SK, Bannister JP, Thomas-Gatewood CM, Jangsangthong W, Jaggar JH. TMEM16A Channels Contribute to the Myogenic Response in Cerebral Arteries. Circ Res. 2012 doi: 10.1161/CIRCRESAHA.112.277145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cox RH, Zhou Z, Tulenko TN. Voltage-gated sodium channels in human aortic smooth muscle cells. J Vasc Res. 1998;35:310–317. doi: 10.1159/000025600. [DOI] [PubMed] [Google Scholar]
  • 12.Crnich R, Amberg GC, Leo MD, Gonzales AL, Tamkun MM, Jaggar JH, Earley S. Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2010;299:C682–694. doi: 10.1152/ajpcell.00101.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Crowder EA, Saha MS, Pace RW, Zhang H, Prestwich GD, Del Negro CA. Phosphatidylinositol 4,5-bisphosphate regulates inspiratory burst activity in the neonatal mouse preBotzinger complex. J Physiol. 2007;582:1047–1058. doi: 10.1113/jphysiol.2007.134577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Davis AJ, Shi J, Pritchard HA, Chadha PS, Leblanc N, Vasilikostas G, Yao Z, Verkman AS, Albert AP, Greenwood IA. Potent vasorelaxant activity of the TMEM16A inhibitor T16A(inh) -A01. Br J Pharmacol. 2012 doi: 10.1111/j.1476-5381.2012.02199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Davis MJ, Donovitz JA, Hood JD. Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol. 1992;262:C1083–1088. doi: 10.1152/ajpcell.1992.262.4.C1083. [DOI] [PubMed] [Google Scholar]
  • 16.Demion M, Bois P, Launay P, Guinamard R. TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells. Cardiovasc Res. 2007;73:531–538. doi: 10.1016/j.cardiores.2006.11.023. [DOI] [PubMed] [Google Scholar]
  • 17.Dhaka A, Viswanath V, Patapoutian A. Trp ion channels and temperature sensation. Annu Rev Neurosci. 2006;29:135–161. doi: 10.1146/annurev.neuro.29.051605.112958. [DOI] [PubMed] [Google Scholar]
  • 18.Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun. 1993;190:968–974. doi: 10.1006/bbrc.1993.1144. [DOI] [PubMed] [Google Scholar]
  • 19.Dietrich A, Mederos YSM, Gollasch M, Gross V, Storch U, Dubrovska G, Obst M, Yildirim E, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC, Gudermann T, Birnbaumer L. Increased vascular smooth muscle contractility in TRPC6−/− mice. Mol Cell Biol. 2005;25:6980–6989. doi: 10.1128/MCB.25.16.6980-6989.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Doughty JM, Miller AL, Langton PD. Non-specificity of chloride channel blockers in rat cerebral arteries: block of the L-type calcium channel. J Physiol. 1998;507(Pt 2):433–439. doi: 10.1111/j.1469-7793.1998.433bt.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dwyer L, Rhee PL, Lowe V, Zheng H, Peri L, Ro S, Sanders KM, Koh SD. Basally activated nonselective cation currents regulate the resting membrane potential in human and monkey colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2011;301:G287–296. doi: 10.1152/ajpgi.00415.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Earley S. Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle. Microcirculation. 2010;17:237–249. doi: 10.1111/j.1549-8719.2010.00026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Earley S, Brayden JE. Transient receptor potential channels and vascular function. Clin Sci (Lond) 2010;119:19–36. doi: 10.1042/CS20090641. [DOI] [PubMed] [Google Scholar]
  • 24.Earley S, Reading S, Brayden JE. Functional Significance of Transient Receptor Potential Channels in Vascular Function. 2007 [PubMed] [Google Scholar]
  • 25.Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol. 2007;292:H2613–2622. doi: 10.1152/ajpheart.01286.2006. [DOI] [PubMed] [Google Scholar]
  • 26.Earley S, Waldron BJ, Brayden JE. Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries. Circ Res. 2004;95:922–929. doi: 10.1161/01.RES.0000147311.54833.03. [DOI] [PubMed] [Google Scholar]
  • 27.England SK, Wooldridge TA, Stekiel WJ, Rusch NJ. Enhanced single-channel K+ current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993;264:H1337–1345. doi: 10.1152/ajpheart.1993.264.5.H1337. [DOI] [PubMed] [Google Scholar]
  • 28.Frohlich ED. Clinical significance of hemodynamic findings in hypertension. Chest. 1973;64:94–99. doi: 10.1378/chest.64.1.94. [DOI] [PubMed] [Google Scholar]
  • 29.Garcia ZI, Bruhl A, Gonzales AL, Earley S. Basal protein kinase Cdelta activity is required for membrane localization and activity of TRPM4 channels in cerebral artery smooth muscle cells. Channels (Austin) 2011;5:210–214. doi: 10.4161/chan.5.3.15111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gonzales AL, Amberg GC, Earley S. Ca2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol. 2010;299:C279–288. doi: 10.1152/ajpcell.00550.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gonzales AL, Earley S. Endogenous cytosolic Ca(2+) buffering is necessary for TRPM4 activity in cerebral artery smooth muscle cells. Cell Calcium. 2012;51:82–93. doi: 10.1016/j.ceca.2011.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gonzales AL, Garcia ZI, Amberg GC, Earley S. Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle. Am J Physiol Cell Physiol. 2010;299:C1195–1202. doi: 10.1152/ajpcell.00269.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, Bois P, Guinamard R. 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol. 2008;153:1697–1705. doi: 10.1038/bjp.2008.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Guinamard R, Demion M, Launay P. Physiological roles of the TRPM4 channel extracted from background currents. Physiology (Bethesda) 2010;25:155–164. doi: 10.1152/physiol.00004.2010. [DOI] [PubMed] [Google Scholar]
  • 35.Guinamard R, Salle L, Simard C. The non-selective monovalent cationic channels TRPM4 and TRPM5. Adv Exp Med Biol. 2011;704:147–171. doi: 10.1007/978-94-007-0265-3_8. [DOI] [PubMed] [Google Scholar]
  • 36.Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res. 1984;55:197–202. doi: 10.1161/01.res.55.2.197. [DOI] [PubMed] [Google Scholar]
  • 37.He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem. 2005;280:10997–11006. doi: 10.1074/jbc.M411797200. [DOI] [PubMed] [Google Scholar]
  • 38.Henrion D, Laher I, Klaasen A, Bevan JA. Myogenic tone of rabbit facial vein and posterior cerebral artery is influenced by changes in extracellular sodium. Am J Physiol. 1994;266:H377–383. doi: 10.1152/ajpheart.1994.266.2.H377. [DOI] [PubMed] [Google Scholar]
  • 39.Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92:145–159. doi: 10.1085/jgp.92.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Iino M. Biphasic Ca2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. J Gen Physiol. 1990;95:1103–1122. doi: 10.1085/jgp.95.6.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Iino M. Calcium dependent inositol trisphosphate-induced calcium release in the guinea-pig taenia caeci. Biochem Biophys Res Commun. 1987;142:47–52. doi: 10.1016/0006-291x(87)90449-9. [DOI] [PubMed] [Google Scholar]
  • 42.Jaggar JH, Wellman GC, Heppner TJ, Porter VA, Perez GJ, Gollasch M, Kleppisch T, Rubart M, Stevenson AS, Lederer WJ, Knot HJ, Bonev AD, Nelson MT. Ca2+ channels, ryanodine receptors and Ca(2+)-activated K+ channels: a functional unit for regulating arterial tone. Acta Physiol Scand. 1998;164:577–587. doi: 10.1046/j.1365-201X.1998.00462.x. [DOI] [PubMed] [Google Scholar]
  • 43.Jarajapu YP, Knot HJ. Relative contribution of Rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am J Physiol Heart Circ Physiol. 2005;289:H1917–1922. doi: 10.1152/ajpheart.01012.2004. [DOI] [PubMed] [Google Scholar]
  • 44.Jarajapu YP, Knot HJ. Role of phospholipase C in development of myogenic tone in rat posterior cerebral arteries. Am J Physiol Heart Circ Physiol. 2002;283:H2234–2238. doi: 10.1152/ajpheart.00624.2002. [DOI] [PubMed] [Google Scholar]
  • 45.Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998;508(Pt 1):199–209. doi: 10.1111/j.1469-7793.1998.199br.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Knot HJ, Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol. 1995;269:H348–355. doi: 10.1152/ajpheart.1995.269.1.H348. [DOI] [PubMed] [Google Scholar]
  • 47.Kotecha N, Hill MA. Myogenic contraction in rat skeletal muscle arterioles: smooth muscle membrane potential and Ca(2+) signaling. Am J Physiol Heart Circ Physiol. 2005;289:H1326–1334. doi: 10.1152/ajpheart.00323.2005. [DOI] [PubMed] [Google Scholar]
  • 48.Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Brink P, Pongs O. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest. 2009;119:2737–2744. doi: 10.1172/JCI38292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Large WA, Wang Q. Characteristics and physiological role of the Ca(2+)-activated Cl- conductance in smooth muscle. Am J Physiol. 1996;271:C435–454. doi: 10.1152/ajpcell.1996.271.2.C435. [DOI] [PubMed] [Google Scholar]
  • 50.Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002;109:397–407. doi: 10.1016/s0092-8674(02)00719-5. [DOI] [PubMed] [Google Scholar]
  • 51.Lee SB, Rhee SG. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol. 1995;7:183–189. doi: 10.1016/0955-0674(95)80026-3. [DOI] [PubMed] [Google Scholar]
  • 52.Marchant JS, Taylor CW. Cooperative activation of IP3 receptors by sequential binding of IP3 and Ca2+ safeguards against spontaneous activity. Curr Biol. 1997;7:510–518. doi: 10.1016/s0960-9822(06)00222-3. [DOI] [PubMed] [Google Scholar]
  • 53.Maruyama Y, Peterson OH. Single-channel currents in isolated patches of plasma membrane from basal surface of pancreatic acini. Nature. 1982;299:159–161. doi: 10.1038/299159a0. [DOI] [PubMed] [Google Scholar]
  • 54.Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londono JE, Uhl S, Voets T, Hummel B, van den Bergh A, Herijgers P, Nilius B, Flockerzi V, Schweda F, Freichel M. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest. 2010;120:3267–3279. doi: 10.1172/JCI41348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Matveev V, Zucker RS, Sherman A. Facilitation through buffer saturation: constraints on endogenous buffering properties. Biophys J. 2004;86:2691–2709. doi: 10.1016/S0006-3495(04)74324-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Meguro K, Iida H, Takano H, Morita T, Sata M, Nagai R, Nakajima T. Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2009;296:H211–219. doi: 10.1152/ajpheart.00960.2008. [DOI] [PubMed] [Google Scholar]
  • 57.Michel AD, Xing M, Thompson KM, Jones CA, Humphrey PP. Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors. Eur J Pharmacol. 2006;534:19–29. doi: 10.1016/j.ejphar.2006.01.009. [DOI] [PubMed] [Google Scholar]
  • 58.Millanvoye E, Freyss-Beguin M, Baudouin-Legros M, Paquet JL, Marche P, Durant S, Meyer P. Growth rate and phospholipase C activity in cardiac and aortic spontaneously hypertensive rat cells. J Hypertens Suppl. 1988;6:S369–371. doi: 10.1097/00004872-198812040-00115. [DOI] [PubMed] [Google Scholar]
  • 59.Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell. 2002;108:595–598. doi: 10.1016/s0092-8674(02)00670-0. [DOI] [PubMed] [Google Scholar]
  • 60.Morgan KG, Leinweber BD. PKC-dependent signalling mechanisms in differentiated smooth muscle. Acta Physiol Scand. 1998;164:495–505. doi: 10.1046/j.1365-201X.1998.00445.x. [DOI] [PubMed] [Google Scholar]
  • 61.Mufti RE, Brett SE, Tran CH, Abd El-Rahman R, Anfinogenova Y, El-Yazbi A, Cole WC, Jones PP, Chen SR, Welsh DG. Intravascular pressure augments cerebral arterial constriction by inducing voltage-insensitive Ca2+ waves. J Physiol. 2010;588:3983–4005. doi: 10.1113/jphysiol.2010.193300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Naraghi M, Neher E. Linearized buffered Ca2+ diffusion in microdomains and its implications for calculation of [Ca2+] at the mouth of a calcium channel. J Neurosci. 1997;17:6961–6973. doi: 10.1523/JNEUROSCI.17-18-06961.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Narayanan D, Adebiyi A, Jaggar JH. Inositol trisphosphate receptors in smooth muscle cells. Am J Physiol Heart Circ Physiol. 2012;302:H2190–2210. doi: 10.1152/ajpheart.01146.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Narayanan J, Imig M, Roman RJ, Harder DR. Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol. 1994;266:H1840–1845. doi: 10.1152/ajpheart.1994.266.5.H1840. [DOI] [PubMed] [Google Scholar]
  • 65.Nelson MT, Conway MA, Knot HJ, Brayden JE. Chloride channel blockers inhibit myogenic tone in rat cerebral arteries. J Physiol. 1997;502(Pt 2):259–264. doi: 10.1111/j.1469-7793.1997.259bk.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799–822. doi: 10.1152/ajpcell.1995.268.4.C799. [DOI] [PubMed] [Google Scholar]
  • 67.Nelson MT, Worley JF. Dihydropyridine inhibition of single calcium channels and contraction in rabbit mesenteric artery depends on voltage. J Physiol. 1989;412:65–91. doi: 10.1113/jphysiol.1989.sp017604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R, Voets T. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006;25:467–478. doi: 10.1038/sj.emboj.7600963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, Wissenbach U, Flockerzi V. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003;278:30813–30820. doi: 10.1074/jbc.M305127200. [DOI] [PubMed] [Google Scholar]
  • 70.Nilius B, Prenen J, Janssens A, Voets T, Droogmans G. Decavanadate modulates gating of TRPM4 cation channels. J Physiol. 2004;560:753–765. doi: 10.1113/jphysiol.2004.070839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX. Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem. 2005;280:6423–6433. doi: 10.1074/jbc.M411089200. [DOI] [PubMed] [Google Scholar]
  • 72.Nilius B, Prenen J, Voets T, Droogmans G. Intracellular nucleotides and polyamines inhibit the Ca2+-activated cation channel TRPM4b. Pflugers Arch. 2004;448:70–75. doi: 10.1007/s00424-003-1221-x. [DOI] [PubMed] [Google Scholar]
  • 73.Osol G, Laher I, Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol. 1993;265:H415–420. doi: 10.1152/ajpheart.1993.265.1.H415. [DOI] [PubMed] [Google Scholar]
  • 74.Pacaud P, Loirand G, Baron A, Mironneau C, Mironneau J. Ca2+ channel activation and membrane depolarization mediated by Cl- channels in response to noradrenaline in vascular myocytes. Br J Pharmacol. 1991;104:1000–1006. doi: 10.1111/j.1476-5381.1991.tb12540.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Partridge LD, Swandulla D. Single Ca-activated cation channels in bursting neurons of Helix. Pflugers Arch. 1987;410:627–631. doi: 10.1007/BF00581323. [DOI] [PubMed] [Google Scholar]
  • 76.Platoshyn O, Remillard CV, Fantozzi I, Sison T, Yuan JX. Identification of functional voltage-gated Na(+) channels in cultured human pulmonary artery smooth muscle cells. Pflugers Arch. 2005;451:380–387. doi: 10.1007/s00424-005-1478-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Quayle JM, McCarron JG, Brayden JE, Nelson MT. Inward rectifier K+ currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol. 1993;265:C1363–1370. doi: 10.1152/ajpcell.1993.265.5.C1363. [DOI] [PubMed] [Google Scholar]
  • 78.Quignard JF, Ryckwaert F, Albat B, Nargeot J, Richard S. A novel tetrodotoxin-sensitive Na+ current in cultured human coronary myocytes. Circ Res. 1997;80:377–382. [PubMed] [Google Scholar]
  • 79.Rahman T, Taylor CW. Dynamic regulation of IP3 receptor clustering and activity by IP3. Channels (Austin) 2009;3:226–232. doi: 10.4161/chan.3.4.9247. [DOI] [PubMed] [Google Scholar]
  • 80.Reading SA, Brayden JE. Central role of TRPM4 channels in cerebral blood flow regulation. Stroke. 2007;38:2322–2328. doi: 10.1161/STROKEAHA.107.483404. [DOI] [PubMed] [Google Scholar]
  • 81.Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE. TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries. Am J Physiol Heart Circ Physiol. 2005;288:H2055–2061. doi: 10.1152/ajpheart.00861.2004. [DOI] [PubMed] [Google Scholar]
  • 82.Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev. 2000;80:1291–1335. doi: 10.1152/physrev.2000.80.4.1291. [DOI] [PubMed] [Google Scholar]
  • 83.Resink TJ, Scott-Burden T, Baur U, Burgin M, Buhler FR. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension. 1989;14:293–303. doi: 10.1161/01.hyp.14.3.293. [DOI] [PubMed] [Google Scholar]
  • 84.Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299–303. doi: 10.1152/ajpcell.1993.265.1.C299. [DOI] [PubMed] [Google Scholar]
  • 85.Rusch NJ, De Lucena RG, Wooldridge TA, England SK, Cowley AW., Jr A Ca(2+)-dependent K+ current is enhanced in arterial membranes of hypertensive rats. Hypertension. 1992;19:301–307. doi: 10.1161/01.hyp.19.4.301. [DOI] [PubMed] [Google Scholar]
  • 86.Rusch NJ, Hermsmeyer K. Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats. Circ Res. 1988;63:997–1002. doi: 10.1161/01.res.63.6.997. [DOI] [PubMed] [Google Scholar]
  • 87.Saleh S, Yeung SY, Prestwich S, Pucovsky V, Greenwood I. Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J Physiol. 2005;568:155–169. doi: 10.1113/jphysiol.2005.090951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Schwarz EC, Wolfs MJ, Tonner S, Wenning AS, Quintana A, Griesemer D, Hoth M. TRP channels in lymphocytes. Handb Exp Pharmacol. 2007:445–456. doi: 10.1007/978-3-540-34891-7_26. [DOI] [PubMed] [Google Scholar]
  • 89.Spassova MA, Hewavitharana T, Xu W, Soboloff J, Gill DL. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci U S A. 2006;103:16586–16591. doi: 10.1073/pnas.0606894103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989;245:177–180. doi: 10.1126/science.2501869. [DOI] [PubMed] [Google Scholar]
  • 91.Sturek M, Hermsmeyer K. Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science. 1986;233:475–478. doi: 10.1126/science.2425434. [DOI] [PubMed] [Google Scholar]
  • 92.Sturgess NC, Hales CN, Ashford ML. Inhibition of a calcium-activated, non-selective cation channel, in a rat insulinoma cell line, by adenine derivatives. FEBS Lett. 1986;208:397–400. doi: 10.1016/0014-5793(86)81056-0. [DOI] [PubMed] [Google Scholar]
  • 93.Sun XP, Callamaras N, Marchant JS, Parker I. A continuum of InsP3-mediated elementary Ca2+ signalling events in Xenopus oocytes. J Physiol. 1998;509(Pt 1):67–80. doi: 10.1111/j.1469-7793.1998.067bo.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Takezawa R, Cheng H, Beck A, Ishikawa J, Launay P, Kubota H, Kinet JP, Fleig A, Yamada T, Penner R. A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol. 2006;69:1413–1420. doi: 10.1124/mol.105.021154. [DOI] [PubMed] [Google Scholar]
  • 95.Talavera K, Yasumatsu K, Voets T, Droogmans G, Shigemura N, Ninomiya Y, Margolskee RF, Nilius B. Heat activation of TRPM5 underlies thermal sensitivity of sweet taste. Nature. 2005;438:1022–1025. doi: 10.1038/nature04248. [DOI] [PubMed] [Google Scholar]
  • 96.Taufiq Ur R, Skupin A, Falcke M, Taylor CW. Clustering of InsP3 receptors by InsP3 retunes their regulation by InsP3 and Ca2+ Nature. 2009;458:655–659. doi: 10.1038/nature07763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Teulon J. Ca2+-activated Non-selective Cation Channels. In: Makato Endo YK, editor. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer Berlin Heidelberg; Masayoshi Mishina: 2000. [Google Scholar]
  • 98.Uehara Y, Ishii M, Ishimitsu T, Sugimoto T. Enhanced phospholipase C activity in the vascular wall of spontaneously hypertensive rats. Hypertension. 1988;11:28–33. doi: 10.1161/01.hyp.11.1.28. [DOI] [PubMed] [Google Scholar]
  • 99.Ullrich ND, Voets T, Prenen J, Vennekens R, Talavera K, Droogmans G, Nilius B. Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium. 2005;37:267–278. doi: 10.1016/j.ceca.2004.11.001. [DOI] [PubMed] [Google Scholar]
  • 100.Vila E, Macrae IM, Reid JL. Differences in inositol phosphate production in blood vessels of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 1991;104:296–300. doi: 10.1111/j.1476-5381.1991.tb12425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Wellman GC, Cartin L, Eckman DM, Stevenson AS, Saundry CM, Lederer WJ, Nelson MT. Membrane depolarization, elevated Ca(2+) entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol Heart Circ Physiol. 2001;281:H2559–2567. doi: 10.1152/ajpheart.2001.281.6.H2559. [DOI] [PubMed] [Google Scholar]
  • 102.Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res. 2002;90:248–250. doi: 10.1161/hh0302.105662. [DOI] [PubMed] [Google Scholar]
  • 103.Welsh DG, Nelson MT, Eckman DM, Brayden JE. Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure. J Physiol. 2000;527(Pt 1):139–148. doi: 10.1111/j.1469-7793.2000.t01-1-00139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Wu L, de Champlain J. Inhibition by cyclic AMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 1996;14:593–599. doi: 10.1097/00004872-199605000-00008. [DOI] [PubMed] [Google Scholar]
  • 105.Zhang Z, Okawa H, Wang Y, Liman ER. Phosphatidylinositol 4,5-bisphosphate rescues TRPM4 channels from desensitization. J Biol Chem. 2005;280:39185–39192. doi: 10.1074/jbc.M506965200. [DOI] [PubMed] [Google Scholar]

RESOURCES